How Data, Connectivity and Technology are Revolutionizing Healthcare
Friday, December 6, 2019 18:30 to 20:30 ATLATL创新研发中心,上海市浦东新区张衡路1077号 +86 21-58332229
Price: ¥50
Friday, December 6, 2019 18:30 to 20:30
Scan and Share
HBS Club of Shanghai, HBS Healthcare Alumni Association, Healthcare Drinks, BayHelix Group, Co-organizer: ATLATL
HBS Club of Shanghai, HBS Healthcare Alumni Association, Healthcare Drinks, BayHelix Group, Co-organizer: ATLATL
Detail
hbsclubshanghai@gmail.com
vivian@peeliventures.com
Views: 4,320
Time: Dec.6th, 6:30-8:30pm 12月6号晚6:30-8:30
Venue: ATLATL Innovation Cluster, 1077 Zhangheng Road, PuDong, Shanghai, China;
ATLATL创新研发中心,上海市浦东新区张衡路1077号 +86 21-58332229
Organizers: HBS Club of Shanghai, HBS Healthcare Alumni Association, Healthcare Drinks, BayHelix Group
Co-organizer: ATLATL创新研发中心
Snacks and Drinks are provided
Keynote Speaker :
Peter Fitzgerald - Dr. Peter Fitzergerald, MD, PhD, Professor Emeritus, Medicine & Engineering at Stanford University
Panelists:
Peter Fitzgerald - Director of the Center for Cardiovascular Technology at Stanford University Medical School
Michael Hua – Head of New Business Development, Johnson & Johnson Medical China
Marie Chavanon – Head of Customer Innovation, Sanofi China
Jonathan Zhu – Partner of Life Science & Government Affairs, and Partner in-charge-of Beijing Office, Heidrick & Struggles
Martin Shen - President, Tencent Trusted Doctors
Cody Yin – Vice President, Eight Roads ( Fidelity ) Ventures
Moderator: Donald Gao – President, HBS Club of Shanghai
AGENDA:
6:30-7:10pm Keynote Speech
7:10-7:20pm Q&A
7:20-8:10pm Panel Discussion
8:10-8:30pm Reception
Keynote Speaker Bio:
Dr. Peter Fitzergerald,
MD, PhD, Professor Emeritus,
Medicine & Engineering at Stanford University
Dr. Peter Fitzgerald currently serves as the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and holds a PhD in Engineering. He is Professor Emeritus in both the Departments of Medicine and Engineering at Stanford. In addition, he heads the Stanford/Asia MedTech innovation program.
Peter Fitzgerald brings decades of experience as a leading interventional cardiologist, start-up founder and venture capitalist. Peter has been principal/founder of twenty-one medical device companies and transitioned fourteen of these start-ups to large medical device companies. Prior to co- founding Triventures, a US/Israeli VC fund, Peter co-founded LVP Capital in San Francisco in 2001, which focused on medical device and biotechnology investments. He has additionally served as a Partner for BioStar Ventures and TransPacific Venture Partners.
Peter has led or participated in over 175 clinical trials, published over 550 manuscripts/chapters, lectures worldwide and is considered a worldwide thought leader on the future trends in healthcare. He has been a consultant for the FDA for the past 15 years focused on medical technology and more recently is one of the FDA’s lead advisors on its digital health strategy. He serves on several boards of directors. Peter is a special advisor to C-level multinational medtech, digital health and consumer electronics multinationals.
Show Detail
Hide Detail
www.yoopay.cn
400.1022.500